Your browser doesn't support javascript.
Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent, Wilson; McFarland, Willi.
  • Vincent W; Department of Epidemiology and Biostatistics, Temple University, Philadelphia, PA, United States of America. Electronic address: wilson.vincent@temple.edu.
  • McFarland W; San Francisco Department of Public Health, San Francisco, CA, United States of America; Department of Medicine, University of California, San Francisco, CA, United States of America. Electronic address: willi_mcfarland@hotmail.com.
Int J Drug Policy ; 110: 103873, 2022 Oct 14.
Article in English | MEDLINE | ID: covidwho-2076059
ABSTRACT

OBJECTIVE:

To identify missed opportunities for healthcare providers to discuss HIV pre-exposure prophylaxis (PrEP) with people who inject drugs (PWID).

METHODS:

Participants were 395 HIV-negative PWID recruited for the 2018 National HIV Behavioral Surveillance survey in San Francisco, California via respondent-driven sampling. Adjusted logistic regression tested whether discussing PrEP with a provider in the last year was associated with sociodemographic characteristics, structural factors, and accessing HIV/STI and substance use treatment services.

RESULTS:

Most PWID (86.3%) reported seeing a healthcare provider, but only 15.0% of these reported discussing PrEP with a healthcare provider. PWID who were sexual minority men had greater odds of having a discussion about PrEP with a healthcare provider than PWID who were heterosexual men (aOR=3.42, 95% CI=1.21-9.73) or heterosexual women (aOR=3.69, 95% CI=1.08-12.62). Additionally, factors associated with discussing PrEP included being tested for HIV (aOR=4.29, 95% CI=1.21-15.29), having a healthcare provider recommend HIV testing (aOR=2.95, 95% CI=1.23-7.06), and receiving free condoms from a prevention program (aOR=5.45, 95% CI=1.78-16.65).

CONCLUSIONS:

In the face of low PrEP uptake, continuing HIV transmission, and many missed opportunities to discussed PrEP (e.g., PWID who are women, substance use treatment services), these findings from San Francisco indicate that healthcare providers and public health efforts need to systematically offer PrEP to PWID. Additional research may clarify missed opportunities in other locations as well as the impact of COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article